JPH0363559B2 - - Google Patents

Info

Publication number
JPH0363559B2
JPH0363559B2 JP57035698A JP3569882A JPH0363559B2 JP H0363559 B2 JPH0363559 B2 JP H0363559B2 JP 57035698 A JP57035698 A JP 57035698A JP 3569882 A JP3569882 A JP 3569882A JP H0363559 B2 JPH0363559 B2 JP H0363559B2
Authority
JP
Japan
Prior art keywords
acyl
alkyl
polypeptides
thr
cys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57035698A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57158745A (en
Inventor
Baueru Uirufuriito
Puresu Yaanosu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS57158745A publication Critical patent/JPS57158745A/ja
Publication of JPH0363559B2 publication Critical patent/JPH0363559B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57035698A 1981-03-06 1982-03-05 Novel n-acyl-polypeptides and manufacture Granted JPS57158745A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1531/81A CH647246A5 (en) 1981-03-06 1981-03-06 Polypeptide derivatives, their preparation and pharmaceutical products which contain these polypeptide derivatives

Publications (2)

Publication Number Publication Date
JPS57158745A JPS57158745A (en) 1982-09-30
JPH0363559B2 true JPH0363559B2 (enExample) 1991-10-01

Family

ID=4212619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57035698A Granted JPS57158745A (en) 1981-03-06 1982-03-05 Novel n-acyl-polypeptides and manufacture

Country Status (4)

Country Link
JP (1) JPS57158745A (enExample)
BE (1) BE892315A (enExample)
CH (1) CH647246A5 (enExample)
ZA (1) ZA821491B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof

Also Published As

Publication number Publication date
JPS57158745A (en) 1982-09-30
BE892315A (fr) 1982-09-01
CH647246A5 (en) 1985-01-15
ZA821491B (en) 1983-10-26

Similar Documents

Publication Publication Date Title
US4435385A (en) N-Acyl-polypeptides and processes for the production thereof
EP0114787B1 (de) Neue Peptidderivate
FI72981C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara polypeptider.
EP0384362B1 (de) Glycinderivate
US4603120A (en) Cyclic octapeptides and pharmaceutical preparations thereof, as well as processes for their manufacture, and their use
EP0187622A2 (en) Somatostatin derivatives
EP0111266A2 (de) Substituierte Tetrapeptide
JPS6218560B2 (enExample)
EP0374098A2 (de) Retrovirale Proteasehemmer
JPS62116595A (ja) 新規化合物、その製法及びそれを含む医薬組成物
GB2045255A (en) Peptide angiotensin converting enzyme inhibitors
JPH0153268B2 (enExample)
JPH0232095A (ja) 免疫機構の機能を仰制する新規ペプチド、それらを含む医薬組成物、並びに前記ペプチド及び医薬組成物の調製方法
JPH0363559B2 (enExample)
DE3328952A1 (de) Neue polypeptide, verfahren zu ihrer herstellung, pharmazeutische praeparate welche sie enthalten, sowie ihre verwendung
CN101190942B (zh) 具有溶血栓活性的化合物、其制备方法和应用
DE2804566A1 (de) Polypeptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE69519182T2 (de) Azapeptid-Derivate
WO1991008199A1 (fr) Derive d'acide amine
DE2628006A1 (de) Tridecapeptid mit gastrinwirkung
US4530837A (en) Peptide derivatives, their preparation process and their pharmaceutical use
JP2617700B2 (ja) 細胞接着活性コア配列の繰り返し構造からなるポリペプチド
CN101168560B (zh) N-取代肽酰胺，其药物组合物与用途
IL34630A (en) Polypeptides and derivatives thereof,their production and pharmaceutical compositions containing them
DE3511206A1 (de) Neue polypeptidderivate, ihre herstellung und pharmazeutische praeparate, welche diese polypeptidderivate enthalten